Estimating the generation time for influenza transmission using household data in the United States.

Publication date: Jan 18, 2025

The generation time, representing the interval between infections in primary and secondary cases, is essential for understanding and predicting the transmission dynamics of seasonal influenza, including the real-time effective reproduction number (Rt). However, comprehensive generation time estimates for seasonal influenza, especially since the 2009 influenza pandemic, are lacking. We estimated the generation time utilizing data from a 7-site case-ascertained household study in the United States over two influenza seasons, 2021/2022 and 2022/2023. More than 200 individuals who tested positive for influenza and their household contacts were enrolled within 7 days of the first illness in the household. All participants were prospectively followed for 10 days, completing daily symptom diaries and collecting nasal swabs, which were then tested for influenza via RT-PCR. We analyzed these data by modifying a previously published Bayesian data augmentation approach that imputes infection times of cases to obtain both intrinsic (assuming no susceptible depletion) and realized (observed within household) generation times. We assessed the robustness of the generation time estimate by varying the incubation period, and generated estimates of the proportion of transmission occurring before symptomatic onset, the infectious period, and the latent period. We estimated a mean intrinsic generation time of 3. 2 (95 % credible interval, CrI: 2. 9-3. 6) days, with a realized household generation time of 2. 8 (95 % CrI: 2. 7-3. 0) days. The generation time exhibited limited sensitivity to incubation period variation. Estimates of the proportion of transmission that occurred before symptom onset, the infectious period, and the latent period were sensitive to variations in the incubation period. Our study contributes to the ongoing efforts to refine estimates of the generation time for influenza. Our estimates, derived from recent data following the COVID-19 pandemic, are consistent with previous pre-pandemic estimates, and will be incorporated into real-time Rt estimation efforts.

Open Access PDF

Concepts Keywords
Depletion Generation interval
Exhibited Household transmission
Influenza Incubation period
Pcr Pre-symptomatic transmission
Respiratory diseases
Serial interval

Semantics

Type Source Name
disease MESH influenza
disease MESH infections
pathway REACTOME Reproduction
disease IDO site
disease IDO symptom
disease IDO infection
disease MESH COVID-19 pandemic
drug DRUGBANK Methionine
disease MESH Seroconversion
disease MESH Coad
drug DRUGBANK Coenzyme M
disease IDO protein
pathway KEGG Influenza A
disease MESH infectious diseases
disease IDO replication
disease IDO history
disease MESH allergies
disease IDO acute infection
disease MESH thrombosis
disease MESH thrombocytopenia
disease MESH syndrome
disease MESH capillary leak syndrome
drug DRUGBANK Ranitidine
disease IDO assay
disease IDO blood
disease MESH emergency
disease MESH Respiratory diseases

Original Article

(Visited 1 times, 1 visits today)